11:15 AM EST - Medicenna Therapeutics Corp. : Was featured in a poster presentation describing the investigator-sponsored NEO-CYT trial at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago last week. Medicenna Therapeutics Corp.
shares T.MDNA are trading up $0.01 at $0.43.
